M. Habib

Intravenous Immunoglobulin (IVIG) Significantly Reduces Respiratory Morbidity in COVID-19 Pneumonia: A Prospective Randomized Trial

R. Kullar, G. Sakoulas, F. Haddad, 2020, medRxiv.

Intravenous Immunoglobulin Plus Methylprednisolone Mitigate Respiratory Morbidity in Coronavirus Disease 2019

R. Kullar, G. Sakoulas, F. Haddad, 2020, Critical care explorations.

Randomized Prospective Open Label Study Shows No Impact on Clinical Outcome of Adding Losartan to Hospitalized COVID-19 Patients with Mild Hypoxemia

R. Kullar, G. Sakoulas, D. Willms, 2021, Infectious Diseases and Therapy.